[1]张 明,周淑红,张 凯,等.特发性肌炎相关肺间质病与特发性肺纤维化的临床比较[J].医学信息,2025,38(07):60-66,104.[doi:10.3969/j.issn.1006-1959.2025.07.010]
　ZHANG Ming,ZHOU Shuhong,ZHANG Kai,et al.Clinical Comparison Between Idiopathic Myositis-associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis[J].Journal of Medical Information,2025,38(07):60-66,104.[doi:10.3969/j.issn.1006-1959.2025.07.010]
点击复制

特发性肌炎相关肺间质病与特发性肺纤维化的临床比较()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
38卷
期数:
2025年07期
页码:
60-66,104
栏目:
论著
出版日期:
2025-04-01

文章信息/Info

Title:
Clinical Comparison Between Idiopathic Myositis-associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis
文章编号:
1006-1959（2025）07-0060-08
作者:
张 明1; 2; 周淑红3; 张 凯4; 陈 英3; 梁刘娜3; 张兆翠3; 潘 亮3
1.甘肃中医药大学第一临床医学院，甘肃 兰州 730000；2.张掖市第二人民医院风湿免疫科，甘肃 张掖 734000；3.甘肃省人民医院免疫风湿科，甘肃 兰州 730000；4.陕西省第二人民医院老年病科，陕西 西安 710000
Author(s):
ZHANG Ming1; 2;  ZHOU Shuhong3;  ZHANG Kai4;  CHEN Ying3;  LIANG Liuna3;  ZHANG Zhaocui3;  PAN Liang3
1.The First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou 730000, Gansu, China;2.Department of Immunorheumatology, Zhangye Second People’s Hospital, Zhangye 734000, Gansu, China;3.Department of Immunorheumatology, Gansu Provi
关键词:
间质性肺疾病; 特发性肌炎; 特发性肺纤维化; MDA5抗体
Keywords:
Interstitial lung disease;  Idiopathic myositis;  Idiopathic pulmonary fibrosis;  MDA5 antibody
分类号:
R563.1+3
DOI:
10.3969/j.issn.1006-1959.2025.07.010
文献标志码:
A
摘要:
目的 比较特发性肌炎间质性肺病（PM/DM-ILD）与特发性间质肺纤维化（IPF）的临床特点。方法 选取我院2018年10月-2021年10月住院治疗的43例诊断为PM/DM-ILD患者，按MDA5抗体检测结果分为MDA5-ILD组（n=13），非MDA5-ILD组（n=30），另外选取同期住院治疗的40例IPF患者作为IPF组。对三组患者一般情况、临床症状、实验室检查、肺功能、胸部HRCT进行回顾性分析。结果 MDA5-ILD组病程短于非MDA5-ILD组及IPF组，丙氨酸转氨酶、GCO评分高于IPF组，高密度脂蛋白低于IPF组，丙氨酸转氨酶、GCO评分高于非MDA5-ILD组（P＜0.016）；非MDA5-ILD组ARS抗体阳性率高于MDA5-ILD组（P＜0.016），肌酶升高阳性率IPF组（P＜0.016），IPF组男性患者、发病年龄、DLCO%pre降低程度、F评分、C评分高于MDA5-ILD组和非MDA5-ILD组（P＜0.016）。三组患者肺功能表现为限制性通气功能伴弥散功能障碍障碍为主，MDA5-ILD组HRCT分型以AIP和OP多见，非MDA5-ILD组HRCT分型以NSIP多见，IPF组HRCT分型以UIP多见。结论 PM/DM-ILD与IPF组临床特点完全不同，MDA5-ILD与非MDA5-ILD临床特点存在差异，其中肌炎抗体、HRCT对ILD的诊治发挥重要作用。
Abstract:
Objective To compare the clinical characteristics of idiopathic myositis interstitial lung disease (PM/DM-ILD) and idiopathic interstitial pulmonary fibrosis (IPF). Methods A total of 43 patients diagnosed with PM/DM-ILD who were hospitalized in our hospital from October 2018 to October 2021 were selected. According to the results of MDA5 antibody test, they were divided into MDA5-ILD group (n=13) and non-MDA5-ILD group (n=30). In addition, 40 patients with IPF who were hospitalized during the same period were selected as IPF group. The general condition, clinical symptoms, laboratory examination, pulmonary function and chest HRCT of the three groups were retrospectively analyzed. Results The course of disease in MDA5-ILD group was shorter than that in non-MDA5-ILD group and IPF group, alanine aminotransferase and GCO scores were higher than those in IPF group, high density lipoprotein was lower than that in IPF group, alanine aminotransferase and GCO scores were higher than those in non-MDA5-ILD group (P<0.016). The positive rate of ARS antibody in non-MDA5-ILD group was higher than that in MDA5-ILD group (P<0.016). The positive rate of muscle enzyme elevation in IPF group was higher than that in MDA5-ILD group (P<0.016). Male patients, age of onset, DLCO% pre reduction, F score and C score in IPF group were higher than those in MDA5-ILD group and non-MDA5-ILD group (P<0.016). The lungfunction of the three groups showed restrictive ventilation function with diffusion dysfunction. The HRCT classification of the MDA5-ILD group was more common with AIP and OP. The HRCT classification of the non-MDA5-ILD group was more common with NSIP. Conclusion The clinical characteristics of PM/DM-ILD are completely different from those of IPF group. There are differences in clinical characteristics between MDA5-ILD and non-MDA5-ILD. Myositis antibody and HRCT play an important role in the diagnosis and treatment of ILD.

参考文献/References:

[1]Nakashima R.Clinical significance of myositis-specific autoantibodies[J].Immunological Medicine,2018,41(3):103-112.[2]Sun KY,Fan Y,Wang YX,et al.Prevalence of interstitial lung disease in polymyositis and dermatomyositis: a meta-analysis from 2000 to 2020[C]//Seminars in arthritis and rheumatism.WB Saunders,2021,51(1):175-191.[3]Kaul B,Cottin V,Collard HR,et al.Variability in global prevalence of interstitial lung disease[J].Frontiers in Medicine,2021,8:751181.[4]Long K,Danoff SK.Interstitial lung disease in polymyositis and dermatomyositis[J].Clinics in Chest Medicine,2019,40(3):561-572.[5]Allenbach Y,Mammen AL,Benveniste O,et al.224th ENMC International Workshop:Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14–16 October 2016[J].Neuromuscular Disorders,2018,28(1):87-99.[6]Raghu G,Remy-Jardin M,Richeldi L,et al.Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline[J].American Journal of Respiratory and Critical Care Medicine,2022,205(9):e18-e47.[7]Oliveira DS,Araújo Filho JA,Paiva AFL,et al.Idiopathic interstitial pneumonias: review of the latest American Thoracic Society/European Respiratory Society classification[J].Radiologia Brasileira,2018,51:321-327.[8]Saldana DC,Hague CJ,Murphy D,et al.Association of computed tomography densitometry with disease severity, functional decline, and survival in systemic sclerosis-associated interstitial lung disease[J].Annals of the American Thoracic Society,2020,17(7):813-820.[9]Ishikawa Y,Iwata S,Hanami K,et al.Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis[J].Arthritis Research & Therapy,2018,20:1-10.[10]Wang H,Shi X,Yang H,et al.Metagenomic next-generation sequencing shotgun for the diagnosis of infection in connective tissue diseases: A retrospective study[J].Frontiers in Cellular and Infection Microbiology,2022,12:865637.[11]Wang XL,Yan R,Zhang Z,et al.Endothelial cell-specific deficiency of the adenosine deaminase ADAR1 aggravates LPS-induced lung injury in mice via an MDA5-independent pathway[J].FEBS letters,2020.[12]Cheng KT,Xiong S,Ye Z,et al.Metagenomic next-generation sequencing shotgun for the diagnosis of infection in connective tissue diseases: A retrospective study[J].Frontiers in Cellular and Infection Microbiology,2022,12:865637.[13]Nagashima T,Kamata Y,Iwamoto M,et al.Liver dysfunction in anti-melanoma differentiation-associated gene 5 antibody-positive patients with dermatomyositis[J].Rheumatology International,2019,39(5):901-909.[14]Huang W,Ren F,Luo L,et al.Clinical Characteristics of Lipid Metabolism in Untreated Patients with Anti-MDA5 Antibody-Positive[J].International Journal of General Medicine,2021,14:2507-2512.[15]Bae SS,Lee YY,Shahbazian A,et al.High-density lipoprotein function is abnormal in idiopathic inflammatory myopathies[J].Rheumatology,2020,59(11):3515-3525.[16]Morris G,Gevezova M,Sarafian V,et al.Redox regulation of the immune response[J].Cellular & Molecular Immunology,2022,19(10):1079-1101.[17]Kogami M,Abe Y,Ando T,et al.Changes in anti-MDA5 antibody titres and serum cytokine levels before and after diagnosis of anti-MDA5 antibody-positive dermatomyositis[J].Rheumatology,2023,62(7):2525-2533.[18]Zuo Y,Ye L,Liu M,et al.Clinical significance of radiological patterns of HRCT and their association with macrophage activation in dermatomyositis[J].Rheumatology,2020,59(10):2829-2837.[19]Ishihara H,Kataoka K,Takei R,et al.Anti MDA5 antibody positive clinically amyopathic dermatomyositis with diffuse alveolar damage diagnosed by transbronchial lung cryobiopsy: A case report[J].Respirology Case Reports,2021,9(11):e0865.[20]Wu W,Guo L,Fu Y,et al.Interstitial lung disease in anti-MDA5 positive dermatomyositis[J].Clinical Reviews in Allergy & Immunology,2021,60:293-304.

相似文献/References:

[1]冯彩云.胺碘酮导致间质性肺病患者的1例分析[J].医学信息,2018,31(10):191.[doi:10.3969/j.issn.1006-1959.2018.10.068]
[2]孟琳非,黄伟健,酆孟洁,等.基于聚类分析对慢性肺部疾病表型的研究进展[J].医学信息,2019,32(07):44.[doi:10.3969/j.issn.1006-1959.2019.07.015]
　MENG Lin-fei,HUANG Wei-jian,FENG Meng-jie,et al.Advances in Research on Phenotypes of Chronic Lung Diseases Based on Cluster Analysis[J].Journal of Medical Information,2019,32(07):44.[doi:10.3969/j.issn.1006-1959.2019.07.015]
[3]李 莘,吴 琦.经支气管冷冻肺活检在间质性肺疾病病理诊断中的应用[J].医学信息,2020,33(21):32.[doi:10.3969/j.issn.1006-1959.2020.21.010]
　LI Xin,WU Qi.Application of Transbronchial Frozen Lung Biopsy in Pathological Diagnosis of Interstitial Lung Disease[J].Journal of Medical Information,2020,33(07):32.[doi:10.3969/j.issn.1006-1959.2020.21.010]
[4]陈 英,周淑红,王 妍,等.硬皮病相关间质性肺病与特发性肺纤维化的临床比较[J].医学信息,2023,36(10):53.[doi:10.3969/j.issn.1006-1959.2023.10.013]
　CHEN Ying,ZHOU Shu-hong,WANG Yan,et al.Clinical Comparison Between Scleroderma Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis[J].Journal of Medical Information,2023,36(07):53.[doi:10.3969/j.issn.1006-1959.2023.10.013]

更新日期/Last Update: 1900-01-01